VivoSim Labs, Inc. (VIVS) stock news · rev $131.0K
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
This VIVS news page leads with what VivoSim Labs, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for VIVS yet. We will not pad this page with generic market recap.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VIVS stock page; for the tape open the quote page.
VIVS stock news FAQ
What are VIVS's latest revenue and net income?
Latest cached VivoSim Labs, Inc. (VIVS) revenue for Mar 31, 2026 was $131.0K. Net income was -$13.8M. Statements: https://lician.com/financials/vivs
How did VIVS revenue change from the prior cached period?
Cached VivoSim Labs, Inc. (VIVS) revenue was down 9.0% from $144.0K (Mar 31, 2025) to $131.0K (Mar 31, 2026). Statements: https://lician.com/financials/vivs
What is VIVS's market cap?
VivoSim Labs, Inc. (VIVS) market cap is $3.5M on the latest cached fundamentals snapshot.
What kind of company is VIVS?
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
Where is VIVS stock news listed?
Cached stock news for VivoSim Labs, Inc. (VIVS) is listed at https://lician.com/news/vivs. Filings: https://lician.com/sec/vivs
Not investment advice.